Cancellation of Mente Device from Australian TGA Register
Filed with ASX · · 2 pages · English
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- Appendix 4E and Annual Report to Shareholders
- Quarterly Update & Appendix 4C
- Pause In Trading
- Quarterly Activities and Cashflow Report
- Response to ASX Price Query
Later from Neurotech International
- Response to Appendix 4C Query
- Mente receives CE Mark renewal for use with ASD Children
- NTI Secures Option to Cannabis Strains Targeting Autism
- Neurotech Proceeds to in vitro trials after Positive Results
- Response to ASX Price and Volume Query
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International